首页> 外文期刊>Clinical and experimental hypertension: CEH >Endothelin-1 and adrenomedullin plasma levels after exposure to fludrocortisone, dexamethasone, and spironolactone
【24h】

Endothelin-1 and adrenomedullin plasma levels after exposure to fludrocortisone, dexamethasone, and spironolactone

机译:接触氟可的松,地塞米松和螺内酯后血浆内皮素-1和肾上腺髓质素水平

获取原文
获取原文并翻译 | 示例
           

摘要

We asked whether plasma concentrations of endothelin-1 (ET-1) or adrenomedullin (ADM) are altered by different activity states of the renin-angiotensin-aldosterone system (RAAS). Levels of ET-1 and ADM were studied in patients with primary aldosteronism (n = 15), essential hypertension (n = 15), and adrenal insufficiency (n = 7). Effects of fludrocortisone, dexamethasone, or spironolactone treatment on ET-1 and ADM levels were also analyzed. Plasma ET-1 and ADM concentrations did not differ significantly between the patient groups. After fludrocortisone, dexamethasone, or spironolactone treatment, both ET-1 and ADM did not change significantly. The data support the hypothesis that the RAAS is not directly linked with the ET-1/ADM system.
机译:我们询问内皮素-1(ET-1)或肾上腺髓质素(ADM)的血浆浓度是否因肾素-血管紧张素-醛固酮系统(RAAS)的不同活动状态而改变。在原发性醛固酮增多症(n = 15),原发性高血压(n = 15)和肾上腺功能不全(n = 7)的患者中研究了ET-1和ADM的水平。还分析了氟可的松,地塞米松或螺内酯对ET-1和ADM水平的影响。两组患者血浆ET-1和ADM浓度无明显差异。氟可的松,地塞米松或螺内酯治疗后,ET-1和ADM均无明显变化。数据支持RAAS不与ET-1 / ADM系统直接链接的假设。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号